Carla Ferri
Papers
1
Total Citations
9
H-Index
1
About
Dr. Carla Ferri has made significant contributions to the early and accurate detection of prostate cancer, with a particular focus on distinguishing aggressive disease from indolent forms. Her research centers on the clinical utility of novel biomarkers, especially the Prostate Health Index (PHI) and its components, including the PSA isoform p2PSA and the percentage of p2PSA to free PSA (%p2PSA). In her highly cited 2015 study, Dr. Ferri demonstrated that PHI outperforms traditional PSA testing in predicting aggressive prostate cancer at radical prostatectomy, offering a more precise tool for risk stratification. This work has helped refine clinical decision-making, potentially reducing unnecessary biopsies and overtreatment. With 9 citations to this seminal paper, her findings have influenced urological practice and biomarker research. Dr. Ferri’s dedication to improving diagnostic accuracy underscores her role as a key contributor to precision oncology in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1